JY
FRLN

Jeff Yass’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Jeff Yass’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,319
Closed -$31K – 14398
2022
Q2 		$31K Buy
+2,319
New +$29.8K ﹤0.01% 12212

Other funds holding FRLN

SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
HCA
Harbor Capital Advisors Chicago, Illinois $1.47B AUM 42.58% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jeff Yass's FRLN Position: Q3 2022 in Review

Jeff Yass sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q3 2022, closing a stake of 2,319 shares — an estimated $31K sold.

Jeff Yass first reported a position in FRLN in Q2 2022 and held it in 1 quarter. The position peaked at $31K in Q2 2022. 14 funds tracked by Wall St. Rank hold FRLN as of Q3 2022.

  • Jeff Yass reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Jeff Yass sold 2,319 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q3 2022, an estimated $31K.
  • Jeff Yass first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q2 2022 and held it in 1 quarter.
  • Jeff Yass's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $31K in Q2 2022.
  • 14 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q3 2022.

Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.